Boston Scientific Co
BSX
Real-time BATS EXCHANGE - 06/20 05:18:57 pm
32.31USD
+1.25%
Business Summary
Healthcare
Healthcare Services
 Healthcare Equipment & Supplies
  Advanced Medical Equipment & Technology
   Advanced Medical Equipment & Technology - NEC
Develops, manufactures and markets medical devices

Boston Scientific Corp. engages in the development, manufacture and marketing of medical devices that are used in interventional medical specialties.

It operates through the following segments: Cardiovascular, Rhythm Management, and MedSurg.

The Cardiovascular segment comprises of technologies or diagnosing and treating coronary artery disease, and other cardiovascular disorders including structural heart conditions.

The Rhythm Management segment develops implantable devices that monitor the heart and deliver electricity to treat cardiac abnormalities.

The MedSurg segment focuses on Endoscopy, which provides devices to diagnose and treat a broad range of gastrointestinal, and pulmonary conditions with innovative and invasive technologies.

The company was founded by John E. Abele and Pete Michael Nicholas on June 29, 1979 and is headquartered in Marlborough, MA.

Number of employees : 29 000 persons.
Sales per Businesses
20162017
USD
(in Million)
%USD
(in Million)
%
Cardiovascular3,61743.1%3,50038.7%
MedSurg3,20438.2%3,37737.3%
Rhythm Management2,25526.9%2,17324%
All Other Corporate Assets----
Other Intangible Assets----
Goodwill----
Amortization Expense----
Goodwill and Intangible Asset Impairment Charges----
Corporate Expenses and Currency Exchange----
Impact of Foreign Currency Fluctuations-690.00-8.2%--
Sales per Regions
20162017
USD
(in Million)
%USD
(in Million)
%
United States4,75956.7%5,16257.1%
Other Countries2,87734.3%3,14934.8%
Japan750.008.9%737.008.1%
Ireland----
Managers
Name Title
Michael F. Mahoney Chairman, President & Chief Executive Officer
John Bradley Sorenson Senior Vice President-Manufacturing & Supply Chain
Edward Mackey Executive Vice President-Operations
Daniel J. Brennan Chief Financial Officer & Executive Vice President
Ian T. Meredith Global Chief Medical Officer & Executive VP
Nelda J. Connors Independent Director
John Edward Sununu Independent Director
Dave J. Roux Independent Director
Edward J. Ludwig Lead Independent Director
Charles J. Dockendorff Independent Director
Shareholders
Name Equities %
Fidelity Management & Research Co. 137,682,402 9.98%
Capital Research & Management Co. (World Investors) 107,405,104 7.78%
The Vanguard Group, Inc. 96,327,820 6.98%
Wellington Management Co. LLP 68,481,549 4.96%
BlackRock Fund Advisors 65,389,089 4.74%
SSgA Funds Management, Inc. 51,608,829 3.74%
PRIMECAP Management Co. 44,720,041 3.24%
Henderson Global Investors Ltd. 41,465,611 3.01%
The Bollard Group LLC 33,655,041 2.44%
JPMorgan Investment Management, Inc. 26,790,672 1.94%
Company contact information
300 way Boston Scientific
MA 01752 Marlborough, Massachusetts
États-Unis (les)

Phone : +1 508 683-5670
Fax : +1 508 683-5675
Internet : http://www.bostonscientific.com
Markets and indexes
- NYSE
- Main Market
- SP 500 /
Stock Exchange Codes
- Bloomberg Code :  BSX:US
- Reuters Code :  BSX
Sector Advanced Medical Equipment & Technology - NEC
1st jan.Capi. (M$)
BOSTON SCIENTIFIC CORPORATION32.96%44 554
THERMO FISHER SCIENTIFIC13.65%85 622
DANAHER CORPORATION7.77%70 744
INTUITIVE SURGICAL34.45%55 591
ILLUMINA32.16%42 461
ROYAL PHILIPS13.48%39 541
EDWARDS LIFESCIENCES CORPORATION35.84%32 272
AGILENT TECHNOLOGIES-2.99%20 787
CERNER CORPORATION-8.93%20 363
ABIOMED, INC.136.69%19 710
WATERS CORPORATION2.85%15 566
RESMED24.93%15 170
OLYMPUS CORP-6.15%12 811
VARIAN MEDICAL SYSTEMS8.94%11 185
HOLOGIC-7.02%10 986
PERKINELMER6.46%8 577
GN STORE NORD41.80%6 424
CARL ZEISS MEDITEC AG18.72%6 248
BRUKER CORPORATION-10.37%4 960
ELEKTA71.22%4 849
QUIDEL CORPORATION57.90%2 601